Wells Fargo’s Indaptus Therapeutics INDP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21 | Sell |
2
-62
| -97% | -$651 | ﹤0.01% | 6311 |
|
|
2025
Q1 | $35 | Hold |
64
| – | – | ﹤0.01% | 6055 |
|
|
2024
Q4 | $54 | Hold |
64
| – | – | ﹤0.01% | 5985 |
|
|
2024
Q3 | $79 | Hold |
64
| – | – | ﹤0.01% | 5896 |
|
|
2024
Q2 | $136 | Sell |
64
-41
| -39% | -$87 | ﹤0.01% | 5840 |
|
|
2024
Q1 | $235 | Buy |
105
+1
| +1% | +$2 | ﹤0.01% | 6059 |
|
|
2023
Q4 | $183 | Buy |
104
+2
| +2% | +$4 | ﹤0.01% | 6189 |
|
|
2023
Q3 | $281 | Buy |
102
+1
| +1% | +$3 | ﹤0.01% | 6123 |
|
|
2023
Q2 | $193 | Buy |
101
+2
| +2% | +$4 | ﹤0.01% | 6402 |
|
|
2023
Q1 | $183 | Buy |
99
+1
| +1% | +$2 | ﹤0.01% | 6474 |
|
|
2022
Q4 | $142 | Buy |
98
+1
| +1% | +$1 | ﹤0.01% | 6389 |
|
|
2022
Q3 | $0 | Sell |
97
-4
| -4% | – | ﹤0.01% | 6652 |
|
|
2022
Q2 | $0 | Buy |
101
+3
| +3% | – | ﹤0.01% | 6814 |
|
|
2022
Q1 | $0 | Sell |
98
-300
| -75% | – | ﹤0.01% | 6933 |
|
|
2021
Q4 | $2K | Buy |
398
+334
| +522% | +$1.68K | ﹤0.01% | 6323 |
|
|
2021
Q3 | $0 | Sell |
64
-189
| -75% | – | ﹤0.01% | 6865 |
|
|
2021
Q2 | $1K | Sell |
253
-3,000
| -92% | -$11.9K | ﹤0.01% | 6331 |
|
|
2021
Q1 | $14K | Buy |
3,253
+3,000
| +1,186% | +$12.9K | ﹤0.01% | 5885 |
|
|
2020
Q4 | $1K | Sell |
253
-4,802
| -95% | -$19K | ﹤0.01% | 6009 |
|
|
2020
Q3 | $1K | Hold |
5,055
| – | – | ﹤0.01% | 5846 |
|
|
2020
Q2 | $1K | Hold |
5,055
| – | – | ﹤0.01% | 5782 |
|
|
2020
Q1 | $1K | Hold |
5,055
| – | – | ﹤0.01% | 5724 |
|
|
2019
Q4 | $3K | Buy |
5,055
+55
| +1% | +$33 | ﹤0.01% | 5720 |
|
|
2019
Q3 | $4K | Buy |
+5,000
| New | +$4K | ﹤0.01% | 5675 |
|
|
2019
Q1 | – | Sell |
-1,000
| Closed | -$8K | – | 5952 |
|
|
2018
Q4 | $8K | Buy |
+1,000
| New | +$8K | ﹤0.01% | 5589 |
|